Skip to main content

Andrew John Partridge

Equibles does not estimate personal net worth.

Get an email with a short summary when GRAIL, Inc. publishes a filing, an earnings call transcript or a press release.

Get GRAL alerts

About Andrew John Partridge

Andrew John Partridge has spoken on 3 earnings calls across 1 company, most recently for GRAIL, Inc. on November 4, 2026. GRAIL, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GRAIL, Inc. includes Dr. Joshua Ofman (CEO), Joshua Ofman (CEO and Board Member), Robert P. Ragusa (CEO and Board Member) and 7 others.

Andrew John Partridge on recent calls

“We saw a lot of excitement from prescribers following the advisory committee. When we actually look at the clinic and health system channel, which, as you know, is our largest business, we actually achieved our volume goals that would set in Q3.”
Other, Q3 2026 Financial Results ·
“Yeah, we pulled forward the Salesforce expansion really on the back of the NHS gallery and App Finder 2 data that we announced earlier in the year. Given how excited we were with both sets of that data, that Salesforce expansion is essentially complete now.”
Other, GRAIL, Inc. Q2 FY2026 Earnings Call ·
“As Bob said, we've seen strong growth through Q1, kind of year over year, and that growth's been across brick and mortar providers, digital health, and employers.”
Other, GRAIL, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at GRAIL, Inc.

Recent activity